Fluorescent probes for bioimaging of potential biomarkers in Parkinson's disease
Parkinson's disease (PD), as the second most common neurodegenerative disease, is
caused by complex pathological processes and currently remains very difficult to treat. PD …
caused by complex pathological processes and currently remains very difficult to treat. PD …
Fluorescent probes for bioimaging of potential biomarkers in Parkinson's disease
L Gao, W Wang, X Wang, F Yang… - Chemical Society …, 2021 - pubmed.ncbi.nlm.nih.gov
Parkinson's disease (PD), as the second most common neurodegenerative disease, is
caused by complex pathological processes and currently remains very difficult to treat. PD …
caused by complex pathological processes and currently remains very difficult to treat. PD …
[引用][C] Fluorescent probes for bioimaging of potential biomarkers in Parkinson's disease
L Gao, W Wang, X Wang, F Yang, L Xie, J Shen… - Chemical Society …, 2021 - cir.nii.ac.jp
Fluorescent probes for bioimaging of potential biomarkers in Parkinson's disease | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Fluorescent probes for bioimaging of potential biomarkers in Parkinson's disease.
L Gao, W Wang, X Wang, F Yang, L Xie… - Chemical Society …, 2021 - europepmc.org
Parkinson's disease (PD), as the second most common neurodegenerative disease, is
caused by complex pathological processes and currently remains very difficult to treat. PD …
caused by complex pathological processes and currently remains very difficult to treat. PD …
[PDF][PDF] Fluorescent probes for bioimaging of potential biomarkers in Parkinson's disease
L Gao, W Wang, X Wang, F Yang, L Xie… - Chemical Society …, 2021 - drive.google.com
Parkinson's disease (PD), the second most common neurodegenerative disease, is
predominantly defined by the functional loss of dopaminergic neurons in the substantia …
predominantly defined by the functional loss of dopaminergic neurons in the substantia …